Associations of cardiovascular and non-cardiovascular comorbidities with dementia risk in patients with diabetes: results from a large UK cohort study
File(s)Zheng2022_Article_AssociationsOfCardiovascularAn.pdf (359.46 KB)
Published version
Author(s)
Type
Journal Article
Abstract
Background
Type 2 diabetes (T2D) is an established risk factor for dementia. However, it remains unclear whether the presence of comorbidities could further increase dementia risk in diabetes patients.
Objectives
To examine the associations between cardiovascular and non-cardiovascular comorbidities and dementia risk in T2D patients.
Design
Population-based cohort study.
Setting
The UK Clinical Practice Research Datalink (CPRD).
Participants
489,205 T2D patients aged over 50 years in the UK CPRD.
Measurements
Major cardiovascular and non-cardiovascular comorbidities were extracted as time-varying exposure variables. The outcome event was dementia incidence based on dementia diagnosis or dementia-specific drug prescription.
Results
During a median of six years follow-up, 33,773 (6.9%) incident dementia cases were observed. Time-varying Cox regressions showed T2D patients with stroke, peripheral vascular disease, atrial fibrillation, heart failure or hypertension were at higher risk of dementia compared to those without such comorbidities (HR [95% CI] = 1.64 [1.59–1.68], 1.37 [1.34–1.41], 1.26 [1.22–1.30], 1.15 [1.11–1.20] or 1.10 [1.03–1.18], respectively). Presence of chronic obstructive pulmonary disease or chronic kidney disease was also associated with increased dementia risk (HR [95% CI] = 1.05 [1.01–1.10] or 1.11 [1.07–1.14]).
Conclusions
A range of cardiovascular and non-cardiovascular comorbidities were associated with further increases of dementia risk in T2D patients. Prevention and effective management of these comorbidities may play a significant role in maintaining cognitive health in T2D patients.
Type 2 diabetes (T2D) is an established risk factor for dementia. However, it remains unclear whether the presence of comorbidities could further increase dementia risk in diabetes patients.
Objectives
To examine the associations between cardiovascular and non-cardiovascular comorbidities and dementia risk in T2D patients.
Design
Population-based cohort study.
Setting
The UK Clinical Practice Research Datalink (CPRD).
Participants
489,205 T2D patients aged over 50 years in the UK CPRD.
Measurements
Major cardiovascular and non-cardiovascular comorbidities were extracted as time-varying exposure variables. The outcome event was dementia incidence based on dementia diagnosis or dementia-specific drug prescription.
Results
During a median of six years follow-up, 33,773 (6.9%) incident dementia cases were observed. Time-varying Cox regressions showed T2D patients with stroke, peripheral vascular disease, atrial fibrillation, heart failure or hypertension were at higher risk of dementia compared to those without such comorbidities (HR [95% CI] = 1.64 [1.59–1.68], 1.37 [1.34–1.41], 1.26 [1.22–1.30], 1.15 [1.11–1.20] or 1.10 [1.03–1.18], respectively). Presence of chronic obstructive pulmonary disease or chronic kidney disease was also associated with increased dementia risk (HR [95% CI] = 1.05 [1.01–1.10] or 1.11 [1.07–1.14]).
Conclusions
A range of cardiovascular and non-cardiovascular comorbidities were associated with further increases of dementia risk in T2D patients. Prevention and effective management of these comorbidities may play a significant role in maintaining cognitive health in T2D patients.
Date Issued
2022-01-14
Date Acceptance
2022-01-04
Citation
JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2022, 9, pp.86-91
ISSN
2274-5807
Publisher
Springer Basel
Start Page
86
End Page
91
Journal / Book Title
JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE
Volume
9
Copyright Statement
© 2022 The Author(s). This article is distributed under the terms of the Creative
Commons Attribution 4.0 International License (http://creativecommons.org/
licenses/by/4.0/), which permits use, duplication, adaptation, distribution and
reproduction in any medium or format, as long as you give appropriate credit
to the original author(s) and the source, provide a link to the Creative Commons
license and indicate if changes were made.
Commons Attribution 4.0 International License (http://creativecommons.org/
licenses/by/4.0/), which permits use, duplication, adaptation, distribution and
reproduction in any medium or format, as long as you give appropriate credit
to the original author(s) and the source, provide a link to the Creative Commons
license and indicate if changes were made.
License URL
Sponsor
Diabetes UK
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000745583500002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Grant Number
18/0005851
Subjects
Science & Technology
Life Sciences & Biomedicine
Clinical Neurology
Neurosciences & Neurology
type 2 diabetes
dementia
comorbidity
cohort
METAANALYSIS
DIAGNOSIS
MELLITUS
DISEASE
TRENDS
Publication Status
Published
Date Publish Online
2022-01-14